<DOC>
	<DOCNO>NCT01065857</DOCNO>
	<brief_summary>The purpose study determine significant difference efficacy acceptability CitraFleet Klean Prep速 ( polyethylene glycol ) preparation gastrointestinal subject undergo colon examination .</brief_summary>
	<brief_title>Safety Efficacy Study CitraFleet ( Sodium Picosulphate ) Evacuating Treatment Prior Colonoscopy .</brief_title>
	<detailed_description>The composite principal objective current study therefore , determine significant difference joint variable efficacy acceptability CitraFleet Klean Prep速 ( polyethylene glycol ) preparation subject undergoing colon examination . The evaluation carry two blind assessor , independent investigator perform procedure ( endoscopist investigator ) . It assess image different section colon : cecum , ascend , transverse , descend rectum subsequent confirmation Principal Investigator agreement reach two blinded assessor whether necessary reach consensus . The evaluation subject 's acceptability assess use 5 point scale assess difficulty take product , degree discomfort cause , taste drug . The secondary objective evaluate safety CitraFleet . In addition second exploratory arm CitraFleet include study ( CitraFleet Exploratory arm ) . The study power make formal statistical comparison arm . Exploratory assessment arm main CitraFleet regimen Klean-Prep make order run future trial design schedule .</detailed_description>
	<mesh_term>Sodium sulfate</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Subjects 18 80 year age . Subjects undergo complete colonoscopy therefore require prior preparation either Klean Prep速 CitraFleet . Subjects capable maintain appropriate oral hydration intestinal preparation process . Subjects provide write informed consent . Subjects use study drug ( KleanPrep速 , CitraFleet ) contraindicate . Subjects communicate study personnel comply study requirement . Subjects undergo complete exploratory diagnostic colonoscopy first time . Severe renal insufficiency . Ascites . Congestive heart failure . Gastrointestinal obstruction , gastric retention , intestinal perforation and/or ileus . Megacolon and/or toxic colitis . Nausea and/or vomit and/or abdominal pain . Severe dehydration . Hypermagnesemia . Rhabdomyolysis . Pregnant woman . Subjects participate clinical trial previous 30 day . Abdominal surgery acute process ( example acute appendicitis ) . Active inflammatory intestinal disease . Known allergy active ingredient excipients study drug . Subjects provide write informed consent . Subjects comply inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Colonoscopy , Preparation , Evacuating , Bowel Cleansing .</keyword>
</DOC>